These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20671944)

  • 1. Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008).
    Imöhl M; Reinert RR; van der Linden M
    Int J Microbiol; 2010; 2010():874189. PubMed ID: 20671944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
    van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
    PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
    Imöhl M; Möller J; Reinert RR; Perniciaro S; van der Linden M; Aktas O
    BMC Infect Dis; 2015 Feb; 15():61. PubMed ID: 25885764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.
    Sá-Leão R; Pinto F; Aguiar S; Nunes S; Carriço JA; Frazão N; Gonçalves-Sousa N; Melo-Cristino J; de Lencastre H; Ramirez M
    J Clin Microbiol; 2011 Apr; 49(4):1369-75. PubMed ID: 21270219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
    Macaj M; Perdochova L; Jakubikova J
    Vaccine; 2023 Jan; 41(2):452-459. PubMed ID: 36470684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study.
    Swarthout TD; Henrion MYR; Thindwa D; Meiring JE; Mbewe M; Kalizang'Oma A; Brown C; Msefula J; Moyo B; Mataya AA; Barnaba S; Pearce E; Gordon M; Goldblatt D; French N; Heyderman RS
    Lancet Infect Dis; 2022 Dec; 22(12):1737-1747. PubMed ID: 36029796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.
    Ardanuy C; Marimón JM; Calatayud L; Giménez M; Alonso M; Grau I; Pallarés R; Pérez-Trallero E; Liñares J
    PLoS One; 2012; 7(8):e43619. PubMed ID: 22928005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
    Cho EY; Choi EH; Kang JH; Kim KH; Kim DS; Kim YJ; Ahn YM; Eun BW; Oh SH; Cha SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Kim JH; Lee H; Lee T; Kim HM; Lee KS; Kim CS; Park SE; Kim YM; Oh CE; Ma SH; Jo DS; Choi YY; Lee J; Bae GR; Park O; Park YJ; Kim ES; Lee HJ
    J Korean Med Sci; 2016 Jul; 31(7):1082-8. PubMed ID: 27366006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and serotype distribution of
    Dai G; Wang T; He Y; Jiang W; Sun H; Chen Z; Zhang T; Yan Y
    Transl Pediatr; 2023 Dec; 12(12):2203-2212. PubMed ID: 38197098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children.
    Varon E; Cohen R; Béchet S; Doit C; Levy C
    Vaccine; 2015 Nov; 33(46):6178-85. PubMed ID: 26476365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?
    Azzari C; Cortimiglia M; Nieddu F; Moriondo M; Indolfi G; Mattei R; Zuliani M; Adriani B; Degl'Innocenti R; Consales G; Aquilini D; Bini G; Di Natale ME; Canessa C; Ricci S; de Vitis E; Mangone G; Bechini A; Bonanni P; Pasinato A; Resti M
    Hum Vaccin Immunother; 2016; 12(2):344-50. PubMed ID: 26647277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes.
    Horácio AN; Silva-Costa C; Lopes JP; Ramirez M; Melo-Cristino J;
    Front Microbiol; 2016; 7():1616. PubMed ID: 27790208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.
    Yildirim I; Stevenson A; Hsu KK; Pelton SI
    Pediatr Infect Dis J; 2012 Oct; 31(10):1016-21. PubMed ID: 22673142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine in the United Kingdom.
    Kandasamy R; Voysey M; Collins S; Berbers G; Robinson H; Noel I; Hughes H; Ndimah S; Gould K; Fry N; Sheppard C; Ladhani S; Snape MD; Hinds J; Pollard AJ
    J Infect Dis; 2020 Mar; 221(8):1361-1370. PubMed ID: 31004136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands.
    Vissers M; Wijmenga-Monsuur AJ; Knol MJ; Badoux P; van Houten MA; van der Ende A; Sanders EAM; Rots NY
    PLoS One; 2018; 13(3):e0194823. PubMed ID: 29601605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.